Perimenopause
Perimenopause is a hormonal condition associated with symptoms that may affect several areas of wellbeing. People may notice hot flushes, somato-vegetative symptoms, urological problems, or changes related to sleep quality.
Perimenopause is categorized as a hormonal condition.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
What studies found for each option, best evidence first.
4 options:1 good evidence1 some evidence2 not enough evidence
AcupuncturepracticeGood evidence it helpsSize of effect: Not known
Good human studies found a benefit, and they mostly agree. This is about what studies measured, not a cure.
All 5 studies with a clear result found a benefit.
A 2025 network meta-analysis of 36 randomized trials ranked routine acupuncture combined with auricular acupuncture highest for improving PSQI scores. A separate meta-analysis of 9 randomized trials reported improvement in PSQI and other outcomes compared with Western sedatives.
Open the Acupuncture pageHatha YogapracticeSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 2 studies with a clear result found a benefit.
A 2015 trial in 40 breast cancer survivors with menopausal symptoms found lower symptom scores with yoga and meditation than with usual care. A separate controlled study in 216 women with perimenopausal symptoms associated yoga with lower blood sugar and maintained cortisol.
Open the Hatha Yoga pageBrisk WalkingpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A 2022 randomized controlled trial in 75 perimenopausal women found increased femoral neck BMD after 48 weeks of brisk walking.
Open the Brisk Walking pageCardiopracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A 12-week aerobic exercise intervention in perimenopausal women was followed by improvements in PSQI and GAD-7 in a quasi-experimental study of 100 women.
Open the Cardio page
May not suit people with this condition
Supplements and practices linked to problems for people with this condition.
Mindfulness MeditationpracticeUnclear
A 2024 cross-sectional study of 199 people associated MBSR with indirect increases in psychological and somatic-vegetative menopausal symptoms, including in BRCA1/2 carriers and breast cancer survivors. This association does not establish that MBSR caused symptoms to worsen.
Open the Mindfulness Meditation page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition4 listedHighest probability, strongest evidence
- →PracticesAcupunctureCertaintyHighSourceRCT
A 2025 network meta-analysis of 36 randomized trials ranked routine acupuncture combined with auricular acupuncture highest for improving PSQI scores. A separate meta-analysis of 9 randomized trials reported improvement in PSQI and other outcomes compared with Western sedatives.
Who was studied
- People with a condition
- Anxiety Disorder
- Depression
- Obesity
- Perimenopause
Open AcupunctureStudy result
Network meta-analysis of 36 RCTs showing routine acupuncture combined with auricular acupuncture ranked highest for improving PSQI scores.
Medium probability(1)
- →PracticesHatha YogaCertaintyMediumSourceClinical
A 2015 trial in 40 breast cancer survivors with menopausal symptoms found lower symptom scores with yoga and meditation than with usual care. A separate controlled study in 216 women with perimenopausal symptoms associated yoga with lower blood sugar and maintained cortisol.
Who was studied
- People with a condition
- Breast Cancer
- Perimenopause
Open Hatha YogaStudy result
Trial in breast cancer survivors with menopausal symptoms showing lower MRS scores with yoga and meditation vs usual care.
Low probability(2)
- →PracticesBrisk WalkingCertaintyLowSourceClinical
A 2022 randomized controlled trial in 75 perimenopausal women found increased femoral neck BMD after 48 weeks of brisk walking.
Who was studied
- People with a condition
- Perimenopause
Open Brisk WalkingStudy result
RCT showing significant increase in femoral neck BMD in perimenopausal women after 48 weeks of brisk walking.
- →PracticesCardioCertaintyLowSourceClinical
A 12-week aerobic exercise intervention in perimenopausal women was followed by improvements in PSQI (p=0.001) and GAD-7 (p=0.002) in a quasi-experimental study of 100 women.
Who was studied
- People with a condition
Open CardioStudy result
Significant improvement in PSQI (p=0.001) and GAD-7 (p=0.002) after 12-week aerobic exercise intervention in perimenopausal women
What to avoid
Interventions recorded as making it worse1 listedHighest probability
- →PracticesMindfulness MeditationCertaintyLowSourceClinical
A 2024 cross-sectional study of 199 people associated MBSR with indirect increases in psychological and somatic-vegetative menopausal symptoms (β=0.108, p=0.003; β=0.029, p=0.033), including in BRCA1/2 carriers and breast cancer survivors. This association does not establish that MBSR caused symptoms to worsen.
Who was studied
- People with a condition
Study result
MBSR was associated with indirect increases in psychological and somatic-vegetative menopausal symptoms (β=0.108, p=0.003; β=0.029, p=0.033) and aggravated symptoms across multiple subgroups including BRCA1/2 carriers and breast cancer survivors.
Open Mindfulness MeditationRationale
MBSR was associated with indirect increases in psychological and somatic-vegetative menopausal symptoms (β=0.108, p=0.003; β=0.029, p=0.033) and aggravated symptoms across multiple subgroups including BRCA1/2 carriers and breast cancer survivors.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Perimenopause is a hormonal condition associated with symptoms that may affect several areas of wellbeing. People may notice hot flushes, somato-vegetative symptoms, urological problems, or changes related to sleep quality. These experiences can vary, and the term refers to a broader pattern of menopausal symptoms rather than one isolated complaint.
Evidence-backed options
The options associated with Perimenopause do not have the same level of support. A review reports that Ashwagandha treatment alleviated menopausal symptoms, including hot flushes and problems in somato-vegetative and urological domains, among peri-menopausal women. This finding indicates potential benefit across several symptom areas, but it does not establish which symptoms may respond most, how quickly changes may appear, or how long treatment was used.
Omega-3 has a more limited evidence picture. A 2023 systematic review of the available randomized controlled trial evidence found that combined analyses did not provide substantial evidence that EPA and DHA improve VSM or sleep quality. This leaves uncertainty about whether Omega-3 meaningfully helps these outcomes in Perimenopause.
Dose, treatment duration, and response timing are not specified for either option here, so the findings cannot be used to compare schedules or predict when effects might appear. The populations and outcomes studied also should not automatically be assumed to represent every person experiencing Perimenopause. A clinician can help place these options in the context of an individual’s symptoms and health history.